News from CNBC Business

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Tariffs Ceo Investors Stock Earnings Shares Stocks Eqs China Nasdaq Cet Investment Markets Wall Street Tesla Trade Nvidia Revenue Stock Market Inflation Securities Economy Class Action Bitcoin Company Us Sales Apple Prices Trade War Sp 500 Crypto Federal Reserve Pvr Ipo Interest Rates Companies Guidance Warren Buffett Amazon Shareholders Berkshire Hathaway Federal Securities Laws Walmart Elon Musk German Securities Trading Act Voting Rights Profit Trading Microsoft Countermeasures Urogen Pharma Adobe Inequality Stimulus Measures Us Tech Companies Us Housing Licensing Consumer Behavior Cleveland Cliffs

Filter by:

Merck × U.S. × CNBC Business ×

CNBC Business • Jun 09, 2025

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...

Read Full Article →